Genetic Mechanisms of Brain Calcification Disorders

Brain calcification disorders encompass a group of rare, often familial, conditions characterised by abnormal deposition of calcium phosphate within cerebral structures, notably the basal ganglia, thalamus and cerebellum. Primary familial brain calcification (PFBC) arises from pathogenic variants in genes governing phosphate transport, vascular integrity and cellular homeostasis. Key mechanisms include impaired inorganic phosphate clearance from the cerebrospinal fluid, dysregulation of neurovascular unit components and defective post-translational modification of membrane proteins. Genetic heterogeneity underpins variable clinical penetrance and phenotypic expression, ranging from movement disorders and cognitive decline to psychiatric features. Recent advances have extended beyond traditional phosphate transporter genes to implicate enzymes involved in protein N-terminal acetylation, as well as tight-junction proteins that compromise blood–brain barrier function. Collectively, these discoveries illuminate convergent pathways in phosphate homeostasis, endothelial permeability and neuronal viability, highlighting potential molecular targets for therapeutic intervention. Ongoing research seeks to bridge genotype–phenotype correlations, refine diagnostic criteria and explore gene-based strategies to halt or reverse calcific lesion formation.

Research from Nature Portfolio

Recent studies have identified biallelic variants in an N-terminal acetyltransferase gene as a novel cause of autosomal recessive PFBC. Loss of enzyme activity undermines N-terminal acetylation of a major phosphate importer, leading to its reduced membrane localisation and diminished extracellular phosphate uptake. This finding establishes a direct biochemical link between protein acetylation and phosphate transporter function in the brain, and introduces post-translational modification as a critical determinant of cerebral phosphate handling. The work not only expands the catalogue of PFBC genes but also underscores the importance of protein maturation pathways in maintaining neurobiological integrity.

Genetic Mechanisms of Brain Calcification Disorders publication trend

The graph below shows the total number of articles in genetic mechanisms of brain calcification disorders across all publications each year (not limited to Nature Index journals).

Technical terms

Primary familial brain calcification (PFBC): An inherited disorder marked by abnormal calcium phosphate deposition in the brain, often affecting movement, cognition and mood.

N-terminal acetylation: A co- or post-translational modification whereby an acetyl group is added to a protein’s N terminus, influencing its stability and localisation.

Sodium-phosphate co-transporter (PiT-1, PiT-2): Membrane proteins mediating cellular uptake of inorganic phosphate, essential for energy metabolism and signalling.

Neurovascular unit: The functional ensemble of endothelial cells, pericytes, astrocytes and neurons that regulates blood–brain barrier integrity and cerebral homeostasis.

Tight junction: A specialised cell–cell adhesion structure in endothelial and epithelial layers that controls paracellular permeability.

References

1. Biallelic NAA60 variants with impaired N-terminal acetylation capacity cause autosomal recessive primary familial brain calcifications. Nature Communications (2024).
2. Slc20a1 and Slc20a2 regulate neuronal plasticity and cognition independently of their phosphate transport ability. Cell Death & Disease (2024).
3. The Genetics of Primary Familial Brain Calcification: A Literature Review. International Journal of Molecular Sciences (2023).
4. Bi-allelic JAM2 Variants Lead to Early-Onset Recessive Primary Familial Brain Calcification. American Journal of Human Genetics (2020).
5. Slc20a2 is critical for maintaining a physiologic inorganic phosphate level in cerebrospinal fluid. Neurogenetics (2015).